Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia
Northwestern University
Northwestern University
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Northwestern University
Northwestern University
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins